期刊文献+

异烟肼植入剂的制备及家兔体内药动学研究 被引量:1

Preparation of Isoniazid Delayed Release Implant and the Release Behavior in Rabbits
原文传递
导出
摘要 目的探讨异烟肼植入剂的制备工艺和体内释放特性。研究异烟肼植入剂在家兔体内的药动学,并与异烟肼普通片进行比较。方法以高分子材料乳酸-乙醇酸共聚物(PLGA)作为基质,采用压模成型法制备异烟肼植入剂。用RP-HPLC测定8只家兔植入异烟肼植入剂后不同时间血浆和组织样品中的异烟肼浓度,并与口服异烟肼普通片比较,通过3P97计算药动学参数。结果 25%的载药量,以丙酮做溶剂制备的植入剂在55 d后,累积释药量达85%以上;在家兔体内可连续释药55 d以上,病灶部位的药物浓度始终高于最低抑菌浓度(0.02μg·mL-1),体内其他组织脏器的浓度明显低于口服给药。结论异烟肼植入剂可以有效的延长体内释药时间、降低全身分布的目的。 OBJECTIVE To prepare isoniazid (INH) implant and evaluate the release behavior in rabbits and compare the phar- macokinetic characteristics and bioavailability of INH implant and INH tablets in rabbits. METHODS Poly (lactic-co-glycolic) acid (PLGA) was chosen as base material, and compression molding forming was used to prepare the INH implant. The concentrations of INH in plasma and organs of 8 rabbits after administrating the INH implant and tablets at different time were determined by RP-HPLC. The pharmacokinetic parameters were computed by software 3P97. RESULTS The aecumulative release percentage of INH from the implant with a drug loading of 25% using acetone as solvent was more than 85% after 55 d. The concentrations at focus were always high- er than the MIC of INH (0. 02 μg · mL-1 ) , while the concentrations at other tissues were less than those after oral administration. CON- CLUSION The prepared INH implant possesses extended-release property in vivo and can decrease the system distribution of INH.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第17期1535-1539,共5页 Chinese Pharmaceutical Journal
关键词 异烟肼植入剂 制备 体外释放 体内释放 isoniazid implant preparation in vitro release in vlvo release
  • 相关文献

参考文献11

  • 1WUZD,WUZH.Surgery(外科学).6thed[M].Bering:Peo-pie’sMedicalPublishingHouse,2003:898-908. 被引量:1
  • 2JEONG B, CHOI Y K, BAE Y H, et al. New biodegradable pol- ymers for injectable drug delivery systems [ J ]. J Controlled Re- lease,1999,62(1-2) :109-114. 被引量:1
  • 3NETZ D J A, SEPULVEDA P, PANDOLFELLI V C, et al. Po- tential use of gelcasting hydroxyapatite porous ceramic as an im- plantable drug delivery system[J], lnt J Pharm, 2001,213( 1- 2) :117-125. 被引量:1
  • 4NORIYUKI K, YUICHIRO O, MOTOTANE H, et al. Controlled intraocular delivery of gancicolovir with use of biodegradable scleral implant in rabbits [ J ]. J Controlled Release, 1995,37 ( 1 - 2 ) : 143-150. 被引量:1
  • 5PAN Z Z, HONG J W. Determination of rifampicin,isoniazid and pyrazinamide in WeiFeiTe tablets by HPLC [ J ]. 广东药学院学报,1998,14(3):203-204. 被引量:1
  • 6∞.P(2005)Vol Ⅱ(中国药典2010年版.二部)[S].2005:41. 被引量:1
  • 7UNSALAN S, SANCAR M, BEKCE B, et al. Therapeutic moni- toring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC [ J ]. Chromatographia, 2005,61 : 595-598. 被引量:1
  • 8蔡宝昌,徐晓月,潘扬,王天山,李彦超.马钱子生物碱在大鼠体内的组织分布[J].中国药理学通报,2004,20(4):421-424. 被引量:28
  • 9姜娟,焦海胜,周素琴,张鸿燕,邱雯,赵慧.异烟肼缓释植入剂的制备和体外释放[J].中国医院药学杂志,2009,29(4):299-302. 被引量:2
  • 10CHENXQ,JINYY,TANGG.NewMedica(新编药物学)16th ed) [ M ]. Beijing: People' s Medical Publishing House, 2007:115-116. 被引量:1

二级参考文献8

  • 1B Jeong, YK Choi, YH Bae, et al. New biodegradable polymers for injectable drug delivery systems[J]. Journal of Controlled Release, 62, ( 1999 ) : 109-114. 被引量:1
  • 2DJA Netz, P Sepulveda, VC Pandolfelli,et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system[J]. International Journal of Pharmaecutiecs, 213, (2001) : 117-125. 被引量:1
  • 3Noriyuki Kunou, Yuichiro Ogura, Mototane Hashizoe,et al. Controlled intraocular delivery of gancicolovir with use of bio degradable scleral implant in rabbits[J]. Journal of Controlled Release,37, (1995) : 143 150. 被引量:1
  • 4.中国药典二部[S].,2005年版.68. 被引量:99
  • 5徐叔云 卞如濂 陈修 主编.药理实验方法学:第2版[M].北京:人民卫生出版社,1992.203. 被引量:6
  • 6史美甫,郭涛,李明.精编药物临床用药必备[M].北京:中国科学技术出版社,2003:873. 被引量:2
  • 7吴在德,吴肇汉.外科学[M].6版.北京:人民卫生出版社,2003:52 被引量:170
  • 8潘兆芝,洪建文.HPLC法测定卫肺特片中利福平、异烟肼和吡嗪酰胺的含量[J].广东药学院学报,1998,14(3):203-204. 被引量:2

共引文献28

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部